With panel discussions on the evolution of cannabis, both as a product and as a sector, RNMKR, a media agency, hosted several prominent cannabis personalities to discuss the future of the market.

A breakfast event last Friday (April 20) featured two different panels, one honing in on how Canada is poised to raise large amounts of capital in the cannabis space, and the other focusing on the impact of marijuana finding its way to retailers.


In a conversation with the Investing News Network (INN), Matei Olaru, CEO of Lift & Co., formerly branded as Lift, predicted that the cannabis market will see another big surge just before legalization happens in Canada, but gave a word of caution to investors for afterwards.

“I would expect [a surge] right before it happens, people pricing in anticipation, and then I would anticipate a couple quarters of medium [lulls] and then actually quite a bit of a correction,” Olaru told INN.

“When you see a lot of these producers with very high valuations not being able to make the revenue that supports the valuations, [it’s] because [they’re] not big enough to sell enough product, or they just couldn’t lock up supply,” he added.

The first panel discussion touched on how the different regulations cannabis will see upon legalization will affect factors like stock prices, the sector as a whole and the way companies operate moving forward.

Lending investor guidance was John Prentice, CEO of Ample Organics, who described his experience trying to raise capital in the market years earlier. He also touched on what current startups and hopeful investors need in order to obtain it.

“Capital will be easier if you have a good plan, an addressable market, you have somewhere to go and you have revenue potential,” Prentice said during the first panel. “If that’s not there, it’s going to be just as difficult as it was [four years ago].”

The second panel of the day focused more closely on cannabis as part of the retail space and mainstream market, including the introduction of the Ontario Cannabis Store, the province’s soon-to-be official regulated cannabis store.

Irie Selkirk, Emblem Cannabis’ (TSXV:EMC) market actuator, was part of this panel and spoke on the importance of educating consumers to help eliminate the stigma attached to cannabis consumption.

“I think as long as that brand and experience is steeped with authenticity and education, that it’s going to gain [the] trust of the consumer,” Selkirk told INN.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less